doxorubicin hydrochloride,brentuximab,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms
['opdivo', 'hodgkin', 'lymphoma', 'nivolumab', 'adcetris', 'nivo', 'bms', 'bmsnews']
nivolumab regimen improves outcomes in previously untreated classic hodgkin lymphoma. alex herrera, md, of tells healio the findings are 'a huge advance.' #asco23 #plenary #opdivo #adcetris 
The content you need, when you need it.